bf/NASDAQ:PHIO_icon.jpeg

COM:PHIOPHARMA

Phio Pharmaceuticals

  • Stock

Last Close

2.53

22/11 21:00

Market Cap

2.61M

Beta: -

Volume Today

14.85K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.03
-
0.01
71.07%
0.00
60.57%
0.00
53.45%
0.00
158.09%
0.01
146.06%
0.00
71.00%
cash per share
80.84K
-
25.51K
68.44%
10.72K
57.97%
12.63K
17.75%
1.05K
91.71%
1.40K
33.27%
180.57
87.06%
37.26
79.37%
22.49
39.64%
10.37
53.91%
0.00
99.96%
company equity multiplier
3.02
-
3.35
10.75%
1.26
62.50%
1.23
1.68%
2.24
81.15%
1.13
49.53%
1.40
23.94%
1.21
13.55%
1.15
5.08%
1.18
3.02%
1.21
2.46%
days of inventory outstanding
days of payables outstanding
1.90K
-
days of sales outstanding
dividend yield
0.12
-
0.01
92.87%
0.00
-
0.33
143,436.74%
ebit per revenue
-52.50
-
-124.31
136.76%
-301.09
142.21%
-474.47
57.59%
-937.47
97.58%
-53.36
94.31%
-427.95
701.97%
ebt per ebit
1.00
-
1.00
0.18%
1.00
0.16%
1.00
0.10%
1.00
0.31%
1.00
0.13%
0.99
0.83%
1.00
0.90%
0.98
1.67%
1.00
1.85%
1.00
0.14%
effective tax rate
0.01
-
0.01
30.68%
0.01
7.57%
0.12
1,299.97%
-0.00
100.47%
0.01
1,483.92%
0.01
-
0.02
170.06%
enterprise value multiple
-1.09
-
-3.02
177.51%
-1.94
35.77%
0.89
146.14%
-1.93
315.20%
1.71
188.57%
0.23
86.41%
0.14
37.54%
0.81
458.81%
0.56
30.88%
-145.52
26,132.75%
fixed asset turnover
2.25
-
0.39
82.79%
0.21
46.24%
0.17
20.10%
0.06
63.71%
0.80
1,226.51%
0.03
96.37%
free cash flow per share
-35.89K
-
-23.58K
34.30%
-7.45K
68.42%
-7.60K
1.99%
-2.84K
62.60%
-705.71
75.16%
-227.01
67.83%
-23.07
89.84%
-11.13
51.75%
-10.78
3.19%
-0.01
99.95%
gross profit margin
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
interest coverage
-872.88
-
14.06K
-
1.50K
-
65.50
95.64%
inventory turnover
long term debt to capitalization
0.07
-
0.04
41.80%
0.01
80.20%
0.02
100.78%
net income per ebt
1
-
1
0%
1
0%
1
0%
0.88
11.52%
1
13.02%
0.99
0.75%
1
0.76%
0.99
0.56%
0.98
0.97%
1
1.55%
net profit margin
-52.44
-
-123.94
136.34%
-300.68
142.59%
-473.37
57.43%
-830.13
75.37%
-53.33
93.58%
-421
689.38%
operating cash flow per share
-35.46K
-
-23.30K
34.29%
-7.39K
68.28%
-7.59K
2.73%
-2.78K
63.36%
-705.24
74.65%
-225.13
68.08%
-23.03
89.77%
-11.09
51.85%
-10.67
3.74%
-0.01
99.95%
operating profit margin
-52.50
-
-124.31
136.76%
-301.09
142.21%
-474.47
57.59%
-937.47
97.58%
-53.36
94.31%
-427.95
701.97%
payables turnover
0.19
-
pretax profit margin
-52.44
-
-123.94
136.34%
-300.68
142.59%
-473.37
57.43%
-938.20
98.20%
-53.33
94.32%
-424.19
695.36%
price fair value
6.89
-
12.81
85.83%
2.81
78.08%
0.44
84.18%
6.85
1,441.03%
0.17
97.50%
0.75
340.81%
0.95
25.73%
0.59
38.26%
0.47
20.08%
204.85
43,698.74%
receivables turnover
return on assets
-1.40
-
-0.96
31.63%
-0.92
4.34%
-0.67
26.72%
-3.04
352.61%
-0.48
84.19%
-1.10
128.95%
-0.56
49.19%
-0.52
6.05%
-0.88
68.07%
-1.16
31.05%
return on capital employed
-1.63
-
-1.12
31.01%
-1.15
2.48%
-0.83
27.88%
-7.67
823.74%
-0.54
92.93%
-1.46
169.05%
-0.65
55.50%
-0.61
5.85%
-1.04
70.30%
-1.40
34.50%
return on equity
-4.23
-
-3.21
24.29%
-1.15
64.13%
-0.83
27.95%
-6.79
719.89%
-0.54
92.02%
-1.54
183.75%
-0.68
56.08%
-0.60
10.83%
-1.04
73.15%
-1.40
34.27%
total debt to capitalization
0.27
-
0.08
-
0.05
43.14%
0.01
71.76%
0.03
106.23%
0.00
83.53%

All numbers in (except ratios and percentages)